Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 17Unknown 7Recruiting 6Enrolling by invitation 6Withdrawn 4Terminated 4Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 369Neoplasms 253Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 192Lung Neoplasms 140Colorectal Neoplasms 137Neoplasm Metastasis 132Pancreatic Neoplasms 131Leukemia, Myeloid, Acute 126Multiple Myeloma 122Lymphoma 114Carcinoma, Hepatocellular 111Ovarian Neoplasms 98Melanoma 97Recurrence 93Leukemia 88Head and Neck Neoplasms 88Leukemia, Lymphocytic, Chronic, B-Cell 86Brain Neoplasms 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Glioblastoma 77Lymphoma, Non-Hodgkin 73Squamous Cell Carcinoma of Head and Neck 71Lymphoma, Follicular 70Lymphoma, Large B-Cell, Diffuse 66Colonic Neoplasms 66Carcinoma, Renal Cell 61Hematologic Neoplasms 59Sarcoma 55Glioma 53

Interventions

Everolimus 1Curcumin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Epilepsy × Clear all
NCT04344626 2023-10-10

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

University of California, Los Angeles

Phase NA Withdrawn
CNS

Focal Cortical Dysplasia, Brain Neoplasms, Encephalitis, Epilepsy, Gliosis, Sturge-Weber Syndrome, Tuberous Sclerosis, Stroke, Hemimegalencephaly, Polymicrogyria

NCT04737174 2022-04-06

ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors

ES Therapeutics Australia Pty Ltd

Phase 2 Withdrawn

Epilepsy

NCT03254680 2018-04-30

Turmeric as Treatment in Epilepsy

NYU Langone Health

Phase NA Withdrawn

Epilepsy, Epilepsies, Myoclonic, Seizures, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT01997255 2016-05-05

Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)

Baylor College of Medicine

Phase 2 Withdrawn

Epilepsy, Glaucoma, Sturge-Weber Syndrome, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡